Global Classical Swine Fever Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

According to APO Research, The global Classical Swine Fever Vaccines market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Classical Swine Fever Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Classical Swine Fever Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Classical Swine Fever Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Classical Swine Fever Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Classical Swine Fever Vaccines include WINSUN, Merial, CAHIC, Chopper Biology, MSD Animal Health (Merck), ChengDu Tecbond, Ceva, Harbin Veterinary Research Institute and Qilu Animal Health Products Factory, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Classical Swine Fever Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Classical Swine Fever Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Classical Swine Fever Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Classical Swine Fever Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Classical Swine Fever Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Classical Swine Fever Vaccines sales, projected growth trends, production technology, application and end-user industry.

Classical Swine Fever Vaccines Segment by Company

WINSUN
Merial
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon

Classical Swine Fever Vaccines Segment by Source
Tissue Culture Origin
Cell Line Origin

Classical Swine Fever Vaccines Segment by Sales Channel
Government Tender
Market Sales

Classical Swine Fever Vaccines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Classical Swine Fever Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Classical Swine Fever Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Classical Swine Fever Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Classical Swine Fever Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Classical Swine Fever Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Classical Swine Fever Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Classical Swine Fever Vaccines Market Size, 2020 VS 2024 VS 2031
1.3 Global Classical Swine Fever Vaccines Market Size Estimates and Forecasts (2020-2031)
1.4 Global Classical Swine Fever Vaccines Sales Estimates and Forecasts (2020-2031)
1.5 Global Classical Swine Fever Vaccines Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Classical Swine Fever Vaccines Market Dynamics
2.1 Classical Swine Fever Vaccines Industry Trends
2.2 Classical Swine Fever Vaccines Industry Drivers
2.3 Classical Swine Fever Vaccines Industry Opportunities and Challenges
2.4 Classical Swine Fever Vaccines Industry Restraints
3 Classical Swine Fever Vaccines Market by Manufacturers
3.1 Global Classical Swine Fever Vaccines Revenue by Manufacturers (2020-2025)
3.2 Global Classical Swine Fever Vaccines Sales by Manufacturers (2020-2025)
3.3 Global Classical Swine Fever Vaccines Average Sales Price by Manufacturers (2020-2025)
3.4 Global Classical Swine Fever Vaccines Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Classical Swine Fever Vaccines Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Classical Swine Fever Vaccines Manufacturers, Product Type & Application
3.7 Global Classical Swine Fever Vaccines Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Classical Swine Fever Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Classical Swine Fever Vaccines Players Market Share by Revenue in 2024
3.8.3 2024 Classical Swine Fever Vaccines Tier 1, Tier 2, and Tier 3
4 Classical Swine Fever Vaccines Market by Type
4.1 Classical Swine Fever Vaccines Type Introduction
4.1.1 Tissue Culture Origin
4.1.2 Cell Line Origin
4.2 Global Classical Swine Fever Vaccines Sales by Type
4.2.1 Global Classical Swine Fever Vaccines Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Classical Swine Fever Vaccines Sales by Type (2020-2031)
4.2.3 Global Classical Swine Fever Vaccines Sales Market Share by Type (2020-2031)
4.3 Global Classical Swine Fever Vaccines Revenue by Type
4.3.1 Global Classical Swine Fever Vaccines Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Classical Swine Fever Vaccines Revenue by Type (2020-2031)
4.3.3 Global Classical Swine Fever Vaccines Revenue Market Share by Type (2020-2031)
5 Classical Swine Fever Vaccines Market by Application
5.1 Classical Swine Fever Vaccines Application Introduction
5.1.1 Government Tender
5.1.2 Market Sales
5.2 Global Classical Swine Fever Vaccines Sales by Application
5.2.1 Global Classical Swine Fever Vaccines Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Classical Swine Fever Vaccines Sales by Application (2020-2031)
5.2.3 Global Classical Swine Fever Vaccines Sales Market Share by Application (2020-2031)
5.3 Global Classical Swine Fever Vaccines Revenue by Application
5.3.1 Global Classical Swine Fever Vaccines Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Classical Swine Fever Vaccines Revenue by Application (2020-2031)
5.3.3 Global Classical Swine Fever Vaccines Revenue Market Share by Application (2020-2031)
6 Global Classical Swine Fever Vaccines Sales by Region
6.1 Global Classical Swine Fever Vaccines Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Classical Swine Fever Vaccines Sales by Region (2020-2031)
6.2.1 Global Classical Swine Fever Vaccines Sales by Region (2020-2025)
6.2.2 Global Classical Swine Fever Vaccines Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Classical Swine Fever Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Classical Swine Fever Vaccines Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Classical Swine Fever Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Classical Swine Fever Vaccines Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Classical Swine Fever Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Classical Swine Fever Vaccines Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Classical Swine Fever Vaccines Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Classical Swine Fever Vaccines Revenue by Region
7.1 Global Classical Swine Fever Vaccines Revenue by Region
7.1.1 Global Classical Swine Fever Vaccines Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Classical Swine Fever Vaccines Revenue by Region (2020-2025)
7.1.3 Global Classical Swine Fever Vaccines Revenue by Region (2026-2031)
7.1.4 Global Classical Swine Fever Vaccines Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Classical Swine Fever Vaccines Revenue (2020-2031)
7.2.2 North America Classical Swine Fever Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Classical Swine Fever Vaccines Revenue (2020-2031)
7.3.2 Europe Classical Swine Fever Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Classical Swine Fever Vaccines Revenue (2020-2031)
7.4.2 Asia-Pacific Classical Swine Fever Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Classical Swine Fever Vaccines Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Classical Swine Fever Vaccines Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 WINSUN
8.1.1 WINSUN Comapny Information
8.1.2 WINSUN Business Overview
8.1.3 WINSUN Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio
8.1.5 WINSUN Recent Developments
8.2 Merial
8.2.1 Merial Comapny Information
8.2.2 Merial Business Overview
8.2.3 Merial Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Merial Classical Swine Fever Vaccines Product Portfolio
8.2.5 Merial Recent Developments
8.3 CAHIC
8.3.1 CAHIC Comapny Information
8.3.2 CAHIC Business Overview
8.3.3 CAHIC Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio
8.3.5 CAHIC Recent Developments
8.4 Chopper Biology
8.4.1 Chopper Biology Comapny Information
8.4.2 Chopper Biology Business Overview
8.4.3 Chopper Biology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Chopper Biology Classical Swine Fever Vaccines Product Portfolio
8.4.5 Chopper Biology Recent Developments
8.5 MSD Animal Health (Merck)
8.5.1 MSD Animal Health (Merck) Comapny Information
8.5.2 MSD Animal Health (Merck) Business Overview
8.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Portfolio
8.5.5 MSD Animal Health (Merck) Recent Developments
8.6 ChengDu Tecbond
8.6.1 ChengDu Tecbond Comapny Information
8.6.2 ChengDu Tecbond Business Overview
8.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Product Portfolio
8.6.5 ChengDu Tecbond Recent Developments
8.7 Ceva
8.7.1 Ceva Comapny Information
8.7.2 Ceva Business Overview
8.7.3 Ceva Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Ceva Classical Swine Fever Vaccines Product Portfolio
8.7.5 Ceva Recent Developments
8.8 Harbin Veterinary Research Institute
8.8.1 Harbin Veterinary Research Institute Comapny Information
8.8.2 Harbin Veterinary Research Institute Business Overview
8.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio
8.8.5 Harbin Veterinary Research Institute Recent Developments
8.9 Qilu Animal Health Products Factory
8.9.1 Qilu Animal Health Products Factory Comapny Information
8.9.2 Qilu Animal Health Products Factory Business Overview
8.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio
8.9.5 Qilu Animal Health Products Factory Recent Developments
8.10 Ringpu Biology
8.10.1 Ringpu Biology Comapny Information
8.10.2 Ringpu Biology Business Overview
8.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio
8.10.5 Ringpu Biology Recent Developments
8.11 DHN
8.11.1 DHN Comapny Information
8.11.2 DHN Business Overview
8.11.3 DHN Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 DHN Classical Swine Fever Vaccines Product Portfolio
8.11.5 DHN Recent Developments
8.12 CAVAC
8.12.1 CAVAC Comapny Information
8.12.2 CAVAC Business Overview
8.12.3 CAVAC Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 CAVAC Classical Swine Fever Vaccines Product Portfolio
8.12.5 CAVAC Recent Developments
8.13 Komipharm
8.13.1 Komipharm Comapny Information
8.13.2 Komipharm Business Overview
8.13.3 Komipharm Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Komipharm Classical Swine Fever Vaccines Product Portfolio
8.13.5 Komipharm Recent Developments
8.14 Agrovet
8.14.1 Agrovet Comapny Information
8.14.2 Agrovet Business Overview
8.14.3 Agrovet Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Agrovet Classical Swine Fever Vaccines Product Portfolio
8.14.5 Agrovet Recent Developments
8.15 Bioveta
8.15.1 Bioveta Comapny Information
8.15.2 Bioveta Business Overview
8.15.3 Bioveta Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Bioveta Classical Swine Fever Vaccines Product Portfolio
8.15.5 Bioveta Recent Developments
8.16 Jinyu Bio-Technology
8.16.1 Jinyu Bio-Technology Comapny Information
8.16.2 Jinyu Bio-Technology Business Overview
8.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio
8.16.5 Jinyu Bio-Technology Recent Developments
8.17 Institutul Pasteur
8.17.1 Institutul Pasteur Comapny Information
8.17.2 Institutul Pasteur Business Overview
8.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio
8.17.5 Institutul Pasteur Recent Developments
8.18 MVP
8.18.1 MVP Comapny Information
8.18.2 MVP Business Overview
8.18.3 MVP Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.18.4 MVP Classical Swine Fever Vaccines Product Portfolio
8.18.5 MVP Recent Developments
8.19 Tecon
8.19.1 Tecon Comapny Information
8.19.2 Tecon Business Overview
8.19.3 Tecon Classical Swine Fever Vaccines Sales, Price, Revenue and Gross Margin (2020-2025)
8.19.4 Tecon Classical Swine Fever Vaccines Product Portfolio
8.19.5 Tecon Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Classical Swine Fever Vaccines Value Chain Analysis
9.1.1 Classical Swine Fever Vaccines Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Classical Swine Fever Vaccines Production Mode & Process
9.2 Classical Swine Fever Vaccines Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Classical Swine Fever Vaccines Distributors
9.2.3 Classical Swine Fever Vaccines Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings